Because both IL-21 and anti-α4β7 therapy individually affect intestinal mucosal immune response, we next performed 16S rRNA gene sequencing on longitudinal fecal samples to characterize changes in microbial communities during both infection and therapeutic intervention (9, 22, 30). Here, IL21 is linked to infection.